Alan Bradley
Founder at Kymab Group Ltd.
Profile
Dr. Alan Bradley is a Chief Executive Officer & Director at T-Therapeutics Ltd., a Chief Scientific Officer at Kymab Group Ltd., an Independent Director at Sieger Healthcare Acquisition Corp.
and a Professor at University of Cambridge.
He is on the Board of Directors at T-Therapeutics Ltd.
and Sieger Healthcare Acquisition Corp.
Dr. Bradley was previously employed as a Founder by Spectral Genomics, Inc., a Professor by Baylor College of Medicine, a Founder by ExpressionEdits Ltd., a Founder by Lexicon Pharmaceuticals, Inc., and an Executive Director by Wellcome Trust Sanger Institute.
He received his undergraduate degree from the University of Cambridge, a graduate degree from the University of Cambridge and a doctorate degree from the University of Cambridge.
Alan Bradley active positions
| Companies | Position | Start |
|---|---|---|
Sieger Healthcare Acquisition Corp.
 Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Director/Board Member | - |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The private company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Founder | - |
| University of Cambridge | Corporate Officer/Principal | - |
Former positions of Alan Bradley
| Companies | Position | End |
|---|---|---|
| ExpressionEdits Ltd. | Founder | - |
| Baylor College of Medicine | Corporate Officer/Principal | - |
| LEXICON PHARMACEUTICALS, INC. | Founder | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Spectral Genomics, Inc.
 Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Founder | - |
Training of Alan Bradley
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The private company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Health Technology |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Finance |
| ExpressionEdits Ltd. | Commercial Services |
- Stock Market
- Insiders
- Alan Bradley